Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced that it will share real-world data about ...

We are positioned for significant expansion in 2025 with the FDA decision on approval of our pre-filled syringe, global CIDP rollout, and label-expansion studies ... and in the role of MuSK at the ...

Neuromuscular disease refers to a group of heterogeneous disorders that impair the function of motor nerves, muscles or neuromuscular junctions. Symptoms can include muscle pain, weakness or ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...

To help combat the nation’s chronic disease crisis, the FDA has announced a proposal for a rule that would require front-of-package labeling for nutritional information. If finalized ...

We are positioned for significant expansion in 2025 with the FDA decision on approval of our pre-filled syringe, global CIDP rollout, and label-expansion studies underway for MG. To further ...

We are positioned for significant expansion in 2025 with the FDA decision on approval of our pre-filled syringe, global CIDP rollout, and label-expansion studies underway for MG. To further support ...

Isolating U.S. companies from cartel activities could be almost impossible given that the criminal groups operate in sectors like agriculture and tourism, leaving some American businesses ...

Terrified residents living next to a notorious junction dubbed 'Britain's worst' have named it 'Death Corner' and claimed that the police and local council won't change the speed limits on it ...